Publicaciones destacadas

Frequency and Characterization of Movement Disorders in Anti-IgLON5 Disease

Gaig C; Compta Y; Heidbreder A; Marti MJ; Titulaer MJ;

(...)

Sabater L; Iranzo A; Cano JS; Dalmau J; Graus F .

Referencia:
Neurology 2021.
Encephalitis with Autoantibodies against the Glutamate Kainate Receptors GluK2

Landa, J; Guasp, M; Miguez-Cabello, F; Guimaraes, J; Mishima, T;

(...)

Gasull, X; Soto, D; Graus, F; Sabater, L; Dalmau, J.

Referencia:
Annals Of Neurology 2021.
Placental transfer of NMDAR antibodies causes reversible alterations in mice

García-Serra A; Radosevic M; Pupak A; Brito V; Ríos J;

(...)

Pedreño M; Joubert B; Ginés S; Planagumà J; Dalmau J .

Referencia:
Neurology-Neuroimmunology & Neuroinflammation 2021.
Sleep disorders in autoimmune encephalitis

Muñoz-Lopetegi A; Graus F; Dalmau J; Santamaria J;

Referencia:
Lancet Neurology 2020.
Clinical features, prognostic factors, and antibody effects in anti-mGluR1 encephalitis

Spatola M; Petit Pedrol M; Maudes E; Simabukuro M; Muñiz-Castrillo S;

(...)

Sillevis Smitt P; Honnorat J; Rosenfeld MR; Graus F; Dalmau J .

Referencia:
Neurology 2020.
Allosteric modulation of NMDA receptors prevents the antibody effects of patients with anti-NMDAR encephalitis

Mannara F; Radosevic M; Planagumà J; Soto D; Aguilar E;

(...)

Quirk M; Dai J; Gasull X; Lewis M; Dalmau J .

Referencia:
Brain 2020.
Reduced serial dependence suggests deficits in synaptic potentiation in anti-NMDAR encephalitis and schizophrenia

Stein, H; Barbosa, J; Rosa-Justicia, M; Prades, L; Morato, A;

(...)

Arino, H; Martinez-Hernandez, E; Castro-Fornieles, J; Dalmau, J; Compte, A.

Referencia:
Nature Communications 2020.
Associations of paediatric demyelinating and encephalitic syndromes with myelin oligodendrocyte glycoprotein antibodies: a multicentre observational study

Armangue T; Olivé-Cirera G; Martínez-Hernandez E; Sepulveda M; Ruiz-Garcia R;

(...)

Vanderver A; Graus F; Saiz A; Dalmau J; Spanish Pediatric anti-MOG Study Group.

Referencia:
Lancet Neurology 2020.